C3 Jian Adds Two Top Oral Healthcare Professionals to Its

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
C3 Jian Adds Two Top Oral Healthcare Professionals to Its Board of Directors

LOS ANGELES, Nov. 10, 2014 (GLOBE NEWSWIRE) -- C3 Jian, Inc., a private company focused on providing improved oral healthcare through new pharmaceutical products, announced the appointment of Steven J. Semmelmayer and Richard P. Bisson to its Board of Directors.

Mr. Semmelmayer joins the C3 Jian board with more than 32 years of experience in the dental industry. He currently serves as Chief Executive Officer of DenMat Holdings LLC, a leading provider of products for dental professionals. Prior to DenMat, Mr. Semmelmayer was the CEO of Discus Dental from 2008 to 2011 when Discus merged with Koninklijke Philips Electronics. Mr. Semmelmayer was CEO and Chairman of the Board of LED Medical Diagnostics from 2006 to 2008; and served in various capacities with Sybron Dental Specialties from 1979 to 2006 including as President, Professional Dental, at the time of that company's $2 billion acquisition by Danaher Corporation. 

Since April 2006, Richard Bisson has served as the Chief Executive Officer, President and Member of the Board of Directors of Water Pik, Inc. Mr. Bisson was also Vice President of Operations at Water Pik Technologies from August 1999 to the time he was appointed CEO. Mr. Bisson is the former Managing Director of Gilardoni S.P.A., an Italian provider of X-ray and ultrasonic products and related medical services. In addition to demonstrated leadership capabilities with senior-level manufacturing positions with Black & Decker and Philips Corp, Mr. Bisson brings over 30 years of experience in all aspects of commercial operations.

"We are extremely excited about Richard and Steve joining our Board of Directors," stated Mr. Todd R. Patrick, President and CEO of C3 Jian, Inc. "Richard's experience in building Water Pik's brand awareness in the oral healthcare industry and the resulting significant increase in revenues and earnings will be a great resource for us as we move our lead product toward eventual commercialization. Having Steve on board, with his vast operational experience and contacts in the dental industry, will be an extraordinary benefit as we examine various sales, marketing/distribution options and worldwide partnering strategies for C16G2. Each of these very successful executives brings a unique and valuable skill set to C3 Jian."

The indication targeted for C16G2, the Company's lead program, is the prevention of dental caries in adults, adolescents and pediatrics. Dental caries, also known as tooth decay or cavities, is rated the most common chronic childhood disease according to the U.S. Surgeon General. In the U.S. alone, over $100 billion is spent annually on oral health expenditures. A majority of these expenses is directly related to dental caries.

"A new dental caries therapy would be a disruptive product that would greatly improve the oral healthcare professionals' ability to serve their patients," said Mr. Bisson.  "If the clinical data continue to hold up, then this really could be a once in a lifetime opportunity. I look forward to contributing to the Company's commercialization strategy."

In September 2014, C3 Jian completed the initial Phase 2 Clinical Trial for C16G2, the first peptide therapeutic derived from the Company's proprietary, pheromone signaling platform technology referred to as STAMPs (Specifically Targeted Antimicrobial Peptides). In a large portion of study subjects, the Company was able to show C16G2 delivered via a gel in dental trays had a 10 fold specific reduction in Streptococcus mutans (S. mutans), the bacterium targeted by C16G2, after one week of treatment. The meaningful reductions in the treated group lasted until the end of the study period, or one week post treatment. By contrast, those study subjects receiving the placebo had increased levels of S. mutans after one week. C16G2 also continues to demonstrate an acceptable safety and tolerability profile. The Company is continuing to test the product candidate in additional Phase 2 studies. 

"I am really thrilled to be joining the board of one of the more innovative companies I have seen in the dental industry," stated Mr. Semmelmayer. "C3 Jian has put together a first class management team and investor group, to go along with a potentially revolutionary lead product.  It is about time the industry advances a new way to manage such a wide-spread and costly disease."

About C3 Jian, Inc.

C3 Jian is a clinical-stage biotechnology company developing and commercializing novel products to diagnose, treat and prevent diseases related to the human microbiome, with an initial focus on improving oral health. C3 is advancing proprietary targeted solutions, which can offer more selective, efficacious and safer treatment modalities than broad spectrum antibiotics. The Company's platform cell signaling STAMP technology has potential applications to a variety of diseases and disorders particularly related to bacterial and fungal infections. C3 Jian is based in Los Angeles, California. For more information about the company, please visit www.c3-jian.com .

CONTACT: Media Contact: Mr. Justin Hsiao, (T) 310.665.2928 x206, Email: jhsiao@c3-jian.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Circuit Adds Gabe Klein as Microtransit Expansion Adviser

Updated Category News Views 29

Municipal mobility is a slow, political grind, not a shiny-app contest, and Circuit’s decision to add Gabe Klein to its board looks aimed squarely at that reality. The all-electric microtransit operator has brought aboard somebody who has worked inside the machinery of city government, federal transportation policy, electrification, venture investing, and transportation...

Continue Reading
Exiger's CEO Honored for Military Support Excellence

Updated Category News Views 256

Recognizing Civilian and Military Leadership When you hear "recognition in the military sector," it isn't just a pat on the back. It's a whole parade of brass hats and high-flyers giving their nods. So, November 10th wasn't just any regular day—Brandon Daniels, CEO of Exiger, gets a shiny, prestigious Five-Star Award for his "extraordinary support" of our military...

Continue Reading
Breakthrough T1D Gala Puts Research Progress First

Updated Category News Views 5

One person living without insulin after a cell-therapy trial is the detail that cuts through all the ballroom polish tonight. Breakthrough T1D's 53rd Annual New York City Promise Gala lands at the Plaza Hotel during National Diabetes Awareness Month, and it carries a message worth handling carefully: research can produce extraordinary outcomes, but one participant's...

Continue Reading
LRM Adds Two IND Studies Testing Injectable PDGF in Skin

Updated Category News Views 14

Under-eye medicine has a nasty habit of outrunning the evidence, which makes LRM's decision to put injectable rhPDGF-BB through more formal study worth watching. Lynch Regenerative Medicine has announced two FDA-accepted INDs for investigator-initiated clinical trials: one examining what the material does inside facial skin, the other testing it for infraorbital...

Continue Reading
COPD Support Program Targets a Costly Care Gap Today

Updated Category News Views 129

Breathing trouble gets shrugged off far too easily, and that casual mistake has consequences. World COPD Day puts chronic obstructive pulmonary disease back in view, with the American Lung Association emphasizing a free Lung Health Navigator program for people living with COPD, their caregivers and families. This is not flashy medicine or a miracle-cure pitch. It is...

Continue Reading
Historic China-Russia-US Summit Aims for Global Stability

Updated Category News Views 91

The Weight of History in Shenzhen When the big players decide to talk face-to-face, it's more than just a photo op. This week in Shenzhen, the leaders of China, Russia, and the United States are doing just that. And let me tell you, it's the kind of gathering that can either stabilize the gears of global politics or grease the wheels of tension. This chinwag isn't just...

Continue Reading
Anycubic Pushes Toward a Smoother 3D Printing Ecosystem

Updated Category News Views 51

Friction Is the Enemy in Consumer 3D Printing A printer that makes a beautiful object only after three failed attempts is not a consumer product; it is a weekend argument with plastic. That is the useful lens for Anycubic's Formnext 2026 showing in Frankfurt on November 18. The company is not merely rolling out FDM and resin machines at Booth F01 in Hall 12.0. It is...

Continue Reading
Oracle Takes AI to Construction's Messy Project Middle

Updated Category News Views 157

A stalled drywall inspection can wreck a schedule faster than any glossy AI pitch can repair it. That is the grimy, practical corner Oracle is aiming at with its latest Oracle Primavera Cloud upgrades: the daily hunt for answers, the repeated logging of familiar risks, and the finger-pointing that starts when a milestone is suddenly in danger. This is not a chatbot being...

Continue Reading
Abacus Global Faces Scrutiny Over Accounting Practices

Updated Category News Views 265

Storm Clouds Gather over Abacus Global Management If it ain't one thing, it's another—at least that's what folks holding the bag with Abacus Global (ABX) are thinking right now. News of a pending investigation has dropped like a lead balloon, and the air is thick with scrutiny over their financial dealings. We're jawing about related-party transactions now under the...

Continue Reading
Ampace Fire Test Gives Data Centers Useful Evidence

Updated Category News Views 134

Battery cabinets are becoming the awkward guest in the AI data-center boom: absolutely necessary, expensive to install, and nobody wants to discover their failure behavior during a real emergency. Ampace’s newly presented PU100 large-scale fire-test results deserve attention for that reason. This is not a magic safety stamp, and the company says the findings apply only...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Digital Twin Advancements in Aerospace and Defense

Updated Category News Views 435

Innovations in Digital Twin Technology for Aerospace and Defense In the fast-evolving world of technology, digital twins have emerged as a transformative asset, especially in the Aerospace and Defense sectors. Recently, the Digital Twin Consortium (DTC) has published an insightful whitepaper titled Aerospace-Defense: Digital Twin Research and Technology Gap Analysis. This...

Continue Reading
Arlo Technologies to Showcase Innovations at Upcoming Conference

Updated Category News Views 126

Arlo Technologies to Present at Piper Sandler Growth Frontiers Conference Arlo Technologies, Inc. (NYSE: ARLO), a top contender in the smart home security landscape, is gearing up to showcase its latest achievements at the Piper Sandler Growth Frontiers Conference. This esteemed event highlights innovative companies leading the way in technology, and Arlo is set to make a...

Continue Reading
Plug's Innovative Trade Desk Revolutionizes EV Market Dynamics

Updated Category News Views 833

Plug's Groundbreaking Initiatives in the Electric Vehicle Sector With a substantial seed funding of $6.7 million, Plug is making significant waves in the electric vehicle (EV) market by launching its pioneering Trade Desk. This service is tailored exclusively for EVs, setting a new precedent in the automotive industry, as it allows dealerships to assess, price, and...

Continue Reading
Exciting Winter and Spring Events at Long Island Aquarium

Updated Category News Views 215

Exciting Upcoming Events at Long Island Aquarium The Long Island Aquarium is thrilled to share its lineup of engaging events for winter and spring. Visitors can expect a variety of experiences designed to entertain the whole family. Whether you're a local resident or just visiting, there's something for everyone at this spectacular underwater haven. Culinary Delights...

Continue Reading
Bakkt Holdings, Inc. Announces Third Quarter Earnings Call

Updated Category News Views 91

Bakkt Holdings, Inc. Sets Conference Call for Q3 Earnings Bakkt Holdings, Inc. (NYSE: BKKT) is making waves as it prepares to discuss its financial results for the third quarter of 2024. The company has scheduled the earnings announcement for a date soon approaching, promising insights that will interest investors and analysts alike. Details of the Earnings Call The...

Continue Reading